Quick Takeaways
- This page summarizes Nir Sassi's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 10 Oct 2024, 16:05.
Nir Sassi - 09 Oct 2024 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)
- Signature
- /s/ Nir Sassi
- Issuer symbol
- INDP
- Transactions as of
- 09 Oct 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 10 Oct 2024, 16:05:13 UTC
- Previous filing
- 23 Jan 2024
- Next filing
- 11 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Nir Sassi filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 10 Oct 2024."
What Changed
- Previous filing in this sequence was filed on 23 Jan 2024.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INDP | Stock Option (Right to Buy) | Award | $0 | +75,000 | $0.000000 | 75,000 | 09 Oct 2024 | Common Stock | 75,000 | $1.10 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The stock option vests and becomes exercisable in full on April 9, 2026, subject to the Reporting Person's continued service to the Issuer through the vesting date. |